| 000 | 01236 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516151933.0 | ||
| 264 | 0 | _c20140924 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1530-0374 | ||
| 024 | 7 |
_a10.1097/GME.0b013e318298d74e _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aManson, Joann E | |
| 245 | 0 | 0 |
_aWhen is the use of aspirin for CVD prevention in women appropriate? _h[electronic resource] |
| 260 |
_bMenopause (New York, N.Y.) _cJan 2014 |
||
| 300 |
_a103-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aPrimary Prevention |
| 650 | 0 | 4 | _aSecondary Prevention |
| 700 | 1 | _aBassuk, Shari S | |
| 773 | 0 |
_tMenopause (New York, N.Y.) _gvol. 21 _gno. 1 _gp. 103-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/GME.0b013e318298d74e _zAvailable from publisher's website |
| 999 |
_c22770461 _d22770461 |
||